Autoamplification of tumor necrosis factor-α: A potential mechanism for the maintenance of elevated tumor necrosis factor-α in male but not female obese mice

American Journal of Pathology

Volumn 168, Issue 2, 2006, Pages 435-444

  Neels, Jaap G ^b   Pandey, Manjula ^b   Hotamisligil, Gökhan S ^c   Samad, Fahumiya ^a  

^a LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MESSENGER RNA; PROTEIN KINASE C; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOAMPLIFICATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; FEMALE; GENDER; GENE AMPLIFICATION; HYPERINSULINEMIA; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

EID: 33144487114     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050699     Document Type: Article

References (56)

1. Beutler B, Cerami A: The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol 1989, 7:625-655
2. Barbara JA, van Ostade X, Lopez A: Tumor necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective. Immunol Cell Biol 1996, 74:434-443
3. Sethi JK, Hotamisligil GS: The role of TNFa in adipocyte metabolism. Cell Dev Biol 1999, 10:19-29
4. Kriegler M, Perez C, DeFay K, Albert I, Lu S: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988, 53:45-53
5. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385:729-733
6. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997, 385:733-736
7. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 1992, 13:151-153
8. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral-proteins-activation, costimulation, and death. Cell 1994, 76:959-962
9. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91
10. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 1995, 95:2409-2415
11. Samad F, Uysal KT, Wiesbrock SM, Pandey M, Hotamisligil GS, Loskutoff DJ: Tumor necrosis factor a is a key component in the obesity-linked elevation of plasminogen activator inhibitor-1. Proc Natl Acad Sci USA 1999, 96:6902-6907
12. Samad F, Yamamoto K, Pandey M, Loskutoff D: Elevated expression of transforming growth factor-b in adipose tissue from obese mice. Mol Med 1997, 3:37-48
13. Sartipy P, Loskutoff DJ: Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003, 100:7265-7270
14. Morin CL, Eckel RH, Marcel T, Pagliassotti MJ: High fat diets elevate tissue-derived tumor necrosis factor-a activity. Endocrinology 1997, 138:4665-4671
15. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996, 274:1377-1379
16. Collart MA, Baeuerle P, Vassalli P: Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kB-like motifs and of constitutive and inducible forms of NF-kB. Mol Cell Biol 1990, 10:1498-1506
17. Wajant H, Henkler F, Scheurich P: The TNF-receptor-associated factor family-scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 2001, 13:389-400
18. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-a function. Nature 1997, 389:610-614
19. Green H, Kehinde O: An established preadipose cell line and its differentiation in culture: II. Factors affecting the adipose conversion. Cell 1975, 5:19-27
20. Pandey M, Tuncman G, Hotamisligil GS, Samad F: Divergent roles for p55 and p75 TNF-a receptors in the induction of plasminogen activator inhibitor-1. Am J Pathol 2003, 162:933-941
21. Samad F, Yamamoto K, Loskutoff DJ: Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: induction by tumor necrosis factor-a and lipopolysaccharide. J Clin Invest 1996, 97:37-46
22. Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 2003, 10:45-65
23. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DCS, Lee YHW, Durkop H, Engelmann H, Scheurich P, Wajant H, Strasser A: Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 1999, 18:3034-3043
24. Weingartner M, Siegmund D, Schlecht U, Fotin-Mleczek M, Scheurich P, Wajant H: Endogenous membrane tumor necrosis factor (TNF) is a potent amplifier of TNF receptor 1-mediated apoptosis. J Biol Chem 2002, 277:34853-34859
25. Messer G, Weiss EH, Baeuerle PA: Tumor necrosis factor beta (TNF-beta) induces binding of the NF-kappa B transcription factor to a high-affinity kappa B element in the TNF-beta promoter. Cytokine 1990, 2:389-397
26. Manolagas SC: The role of IL-6 type cytokines and their receptors in bone. Ann NY Acad Sci 1998, 840:194-204
27. Hiscott J, Marois J, Garoufalis J, Daddario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G, Fenton M: Characterization of a functional NF-kappa-B site in the human interleukin-1-beta promoter-evidence for a positive autoregulatory loop. Mol Cell Biol 1993, 13:6231-6240
28. Bazzoni F, Beutler B: How do tumor necrosis factor receptors work? J Inflamm 1995, 45:221-238
29. Tartaglia LA, Rothe M, Hu YF, Goeddel DV: Tumor necrosis factor's cytotoxic activity is signaled by he p55 TNF receptor. Cell 1993, 73:213-216
30. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino Jr MA, Goeddel DV: The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 1991, 88:9292-9296
31. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993, 74:845-853
32. Uysal KT, Wiesbrock SM, Hotamisligil GS: Functional analysis of tumor necrosis factor (TNF) receptors in TNF-a-mediated insulin resistance in genetic obesity. Endocrinology 1998, 139:4832-4838
33. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808
34. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, Vidai H, Laville M, Barsh GS, Basdevant A, Stich V, Cancello R, Langin D: Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004, 18:1657-1669
35. Fernandez-Real JM, Casamitjana R, Ricart-Engel W: Leptin is involved in gender-related differences in insulin sensitivity. Clin Endocrinol (Oxf) 1998, 49:505-511
36. Frias JP, Macaraeg GB, Ofrecio J, Yu JG, Olefsky JM, Kruszynska YT: Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes 2001, 50:1344-1350
37. Hevener A, Reichart D, Janez A, Olefsky J: Female rats do not exhibit free fatty acid-induced insulin resistance. Diabetes 2002, 51:1907-1912
38. Pfeiffer A, Janott J, Mohlig M, Ristow M, Rochlitz H, Busch K, Schatz H, Schifferdecker E: Circulating tumor necrosis factor alpha is elevated in male but not in female patients with type II diabetes mellitus. Hormone Metab Res 1997, 29:111-114
39. Lundholm L, Moverare S, Steffensen KR, Nilsson M, Otsuki M, Ohlsson C, Gustafsson JA, Dahlman-Wright K: Gene expression profiling identifies liver X receptor alpha as an estrogen-regulated gene in mouse adipose tissue. J Mol Endocrinol 2004, 32:879-892
40. Landis MS, Patel HV, Capone JP: Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-alpha from human monocytes. J Biol Chem 2002, 277:4713-4721
41. Sakamoto T, Woodcock-Mitchell J, Marutsuka K, Mitchell JJ, Sobel BE, Fujii S: TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes. Am J Physiol 1999, 276:C1391-C1397
42. Huang L, Li C: Leptin: a multifunctional hormone. Cell Res 2000, 10:81-92
43. Shore SA, Rivera-Sanchez YM, Schwartzman IN, Johnston RA: Responses to ozone are increased in obese mice. J Appl Physiol 2003, 95:938-945
44. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM: Leptin regulates proinflammatory immune responses. FASEB J 1998, 12:57-65
45. Newton AC: Protein kinase C: structure, function, and regulation. J Biol Chem 1995, 270:28495-28498
46. Christensen RL, Shade DL, Graves CB, McDonald JM: Evidence that protein-kinase-C is involved in regulating glucose-transport in the adipocyte. Int J Biochem 1987, 19:259-265
47. Alexander JP, Acott TS; Involvement of protein kinase C in TNF alpha regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci 2001, 42:2831-2838
48. Pandey M, Loskutoff DJ, Samad F: Molecular mechanisms of tumor necrosis factor-alpha-mediated plasminogen activator inhibitor-1 expression in adipocytes. FASEB J 2005, 19:1317-1319
49. Berg AH, Lin Y, Lisanti MP, Scherer PE: Adipocyte differentiation induces dynamic changes in NF-kappa B expression and activity. Am J Physiol 2004, 287:E1178-E1188
50. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF: Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes-nuclear factor-kappa B activation by TNF-alpha is obligatory. Diabetes 2002, 51:1319-1336
51. Skurk T, van Harmelen V, Hauner H: Angiotensin Il stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappa B. Arterioscler Thromb Vasc Biol 2004, 24:1199-1203
52. Ogihara T, Asano T, Katagiri H, Sakoda H, Anai M, Shojima N, Ono H, Fujishiro M, Kushiyama A, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Gotoh Y, Komuro I, Fujita T: Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia 2004, 47:794-805
53. Chae GN, Kwak SJ: NF-kappa B is involved in the TNF-alpha induced inhibition of the differentiation of 3T3-L1 cells by reducing PPAR gamma expression. Exp Mol Med 2003, 35:431-437
54. Yuan MS, Konstantopoulos N, Lee JS, Hansen L, Li ZW, Karin M, Shoelson SE: Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK beta. Science 2001, 293:1673-1677
55. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI: Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002, 109:1321-1326
56. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005, 11:191-198